This new program was approved by the Graduate Medical Education Committee on August 31, 2006. The first trainee began in July 2007.
One or two years. The second year is optional and would include an opportunity to obtain a Master’s Degree as an incidental component to the training.
Prerequisite Training / Selection Criteria
The trainee should preferably be a fully trained surgeon. They must have completed a residency in pediatric surgery, general surgery, otolaryngology or plastic surgery.
Goals & Objectives
Individuals will participate in the broad clinical and academic experience now available in surgical oncology and vascular anomalies under the supervision of Dr. Dasgupta and other pediatric surgical oncology attendings.
The surgical oncology fellowship will provide a comprehensive understanding of tumors commonly treated by pediatric surgeons. Faculty involved will include Dr. Dasgupta, Dr. Tiao, and Dr. von Allmen. The oncology program at Cincinnati Children's Hospital Medical Center is one of the largest in the country. There are content experts and leaders in COG both on the medical and surgical side for all solid tumors that are seen by surgeons. The fellow will develop a complete understanding of diagnosis, treatment (surgical and non surgical) and surgical procedures in pediatric cancer. The fellow will have rotations on the medical oncology service, radiation oncology, and spend time with the survivorship program and pathology. These experiences, as well as being involved in research projects both from the institution and pediatric surgical research collaborative (PSDRC), will provide an excellent background for a future career in pediatric surgical oncology.
Vascular anomalies are very common disorders that affect approximately 15% of all children. Throughout the USA, vascular anomalies are frequently misdiagnosed and often inappropriately treated. There is a significant need to train subspecialists with expertise in managing these types of patients. Our program is one of two formal training programs for vascular anomalies in North America.
Currently, the Hemangioma and Vascular Malformation Clinic (HVMC) has more than 6,000 active patients and new patient accrual is exceeding 700 patients per year. Our Center is one of 5 comprehensive Vascular Anomalies programs in North America and sees one of the largest volumes of patients from all over the world. The fellow will interact with a superb interdisciplinary faculty with internationally acclaimed expertise in this field. The faculty members are engaged in clinical and translational research.
None at this time.